首页> 外文期刊>Chemistry and Physics of Lipids >Design Design and synthesis of a novel glycosphingolipid derived from polyhydroxy 2-pyrrolidinone and phytoceramide appended by a 1,2,3-triazole linker
【24h】

Design Design and synthesis of a novel glycosphingolipid derived from polyhydroxy 2-pyrrolidinone and phytoceramide appended by a 1,2,3-triazole linker

机译:设计并合成由1,2,3-三唑连接基附加的多羟基2-吡咯烷酮和植物神经酰胺衍生的新型鞘糖脂

获取原文
获取原文并翻译 | 示例
           

摘要

Synthetic analogs of glycosphingolipids (GSLs) have been demonstrated as potential therapeutic interventions in certain patho-physiological conditions. This article reviews reports of various bioactive synthetic GSLs, emanated from the Bittman laboratory. KRN7000, a synthetic GSL which is a alpha-galactosylceramide (alpha-GalCer) is a potent immunomodulatory agent. Bittman et al. reported several modifications of C-glycosides of KRN7000 with an eye towards achieving selective cytokine response during iNKT cell activation. However, GSLs with azasugar variants were not explored which inspired us to derive a polyhydroxy 2-pyrrolidinone azasugar from D-galactose and append to the phytoceramide via a 1,2,3-triazole linker to afford GSL analog 12. This novel GSL analog 12 may be used to explore the immunomodulatory activity, and other biological activities against targets involving iminosugar or azasugar based therapeutics. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
机译:糖鞘脂(GSLs)的合成类似物已被证明是在某些病理生理条件下的潜在治疗手段。本文回顾了来自Bittman实验室的各种生物活性合成GSL的报告。 KRN7000,一种合成的GSL,是一种α-半乳糖苷神经酰胺(α-GalCer),是一种有效的免疫调节剂。 Bittman等。为了报道在iNKT细胞活化过程中实现选择性细胞因子应答,KRN7000的C-糖苷的几种修饰。然而,没有探索具有氮杂糖变体的GSL,这启发了我们从D-半乳糖衍生出多羟基2-吡咯烷酮氮杂糖,并通过1,2,3-三唑连接基附加到植物神经酰胺上,从而提供了GSL类似物12。这种新颖的GSL类似物12可用于探索针对涉及亚氨基糖或氮杂糖的治疗剂的靶标的免疫调节活性和其他生物活性。 (C)2015 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号